Recommendations To The Administration, Congress, And Other Federal, State And Local Leaders From Public Health, Medical, Policy And Legal Experts.
By Christen Linke Young, JD, Kavita Patel, Howard P. Forman, Elizabeth Fowler, Megan L. Ranney, Ruth J. Katz, Sara Rosenbaum, Timothy Stoltzfus Jost, Abbe R. Gluck, Erica Turret, Suhas Gondi and Adam Beckman
Drugs already being used to treat high blood pressure and cholesterol could reduce the risk of Alzheimer’s disease and dementia, according to a new Schaeffer Center study of nearly 700,000 Medicare beneficiaries.
The researchers analyzed how long it took Los Angeles County emergency medical services to transport patients to CSCs, and found that traffic conditions affect consistent access, particularly in socioeconomically disadvantaged neighborhoods.
Utilization of emergency department services for mental health-related visits can be challenging for hospitals to manage. This study showed mental health-related visits grew by 56 percent for pediatric patients and by almost 41 percent for adults.
Researcher Neeraj Sood has explored innovative payment models as a strategy for government entities to be able to pay for lifesaving cures that could eradicate diseases like hepatitis C. Louisiana, with some input from Sood, has just implemented a modified version of a subscription model to pay for Hep C treatments.
A report on Canadian readiness to deal with new Alzheimer’s disease treatments co-authored by Jakub Hlávka found that average wait times could reach 28 months and that the most pressing issue is a lack of dementia specialists.